Dr. Hwang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1021 Morehead Medical Dr
Ste A
Charlotte, NC 28204Phone+1 980-442-2000Fax+1 980-442-6141
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 1998 - 2001- UPMC Medical EducationResidency, Internal Medicine, 1995 - 1998
University of Pittsburgh School of MedicineClass of 1995
Certifications & Licensure
NC State Medical License 2013 - 2025
DC State Medical License 2001 - 2014
MD State Medical License 2010 - 2014
VA State Medical License 2001 - 2010
PA State Medical License 1996 - 2002- American Board of Internal Medicine Medical Oncology
Clinical Trials
- An Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2009 Jan 01
- A Phase 2 Study of Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Junction (GEJ) Cancer Start of enrollment: 2015 Jul 07
- A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies Start of enrollment: 2016 Feb 19
- Join now to see all
Publications & Presentations
PubMed
- 82 citationsSomatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion.Debyani Chakravarty, Amber Johnson, Jeffrey Sklar, Neal I Lindeman, Kathleen Moore
Journal of Clinical Oncology. 2022-04-10 - 140 citationsComparative molecular analyses of left-sided colon, right-sided colon, and rectal cancersMohamed E. Salem, Benjamin A. Weinberg, Joanne Xiu, Wafik S. El-Deiry, Jimmy J. Hwang
Oncotarget. 2017-09-23 - 16 citationsA phase 1 dose-escalation study of checkpoint kinase 1 (CHK1) inhibitor prexasertib in combination with p38 mitogen-activated protein kinase (p38 MAPK) inhibitor ralim...Johanna C. Bendell, Helge Bischoff, Jimmy Hwang, Hans Christian Reinhardt, Thomas Zander
Investigational New Drugs. 2020-08-01
Authored Content
- ASCO GI: Updates in Rectal Cancer and the FIGHT StudyJanuary 2021
Press Mentions
Early Discovery of Liver Disease Improves Chances to Cure Liver CancerOctober 21st, 2021- ASCO GI: Updates in Rectal Cancer and the FIGHT StudyJanuary 25th, 2021
I’ll Never Stop FightingAugust 22nd, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
